- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.08 | 0.06 | 36.06 |
| EPS, GAAP | 0.08 | 0.06 | 0.06 |
| Consensus Estimate | 0.10 | 0.05 | 131.11 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.43 | 0.30 | 41.15 |
| EPS, GAAP | 0.41 | 0.22 | 88.25 |
| Consensus Estimate | 0.33 | 0.00 | 0.00 |
| AKRX | Industry Average | |
| P/E (TTM) | 32.47 | NA |
| P/E (Forward) | 26.21 | NA |
| PEG Ratio | 0.84 | 2.17 |
| Price/Sales | 7.94 | 4.18 |
| Beta | 1.41 | 0.62 |
| 4/10/2012 | Stocks To Watch: ViroPharma, Supervalu, Sony (WSJ.com) |
| 3/8/2012 | High-risk, high-reward small caps. (The Motley Fool) |
| 3/6/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)